BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38744246)

  • 21. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract.
    Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD
    Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis.
    Boirivant M; Amendola A; Butera A; Sanchez M; Xu L; Marinaro M; Kitani A; Di Giacinto C; Strober W; Fuss IJ
    Gastroenterology; 2008 Nov; 135(5):1612-1623.e5. PubMed ID: 18765239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer.
    Egelston C; Guo W; Yost S; Lee JS; Rose D; Avalos C; Ye J; Frankel P; Schmolze D; Waisman J; Lee P; Yuan Y
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33757987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. iNKT Cells Suppress Pathogenic NK1.1
    Lee SW; Park HJ; Cheon JH; Wu L; Van Kaer L; Hong S
    Front Immunol; 2018; 9():2168. PubMed ID: 30333822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.
    Coutzac C; Adam J; Soularue E; Collins M; Racine A; Mussini C; Boselli L; Kamsukom N; Mateus C; Charrier M; Cassard L; Planchard D; Ribrag V; Fizazi K; Loriot Y; Lepage P; Scoazec JY; Robert C; Carbonnel F; Chaput N
    J Crohns Colitis; 2017 Oct; 11(10):1238-1246. PubMed ID: 28967957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
    Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
    Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ScRNA-seq defines dynamic T-cell subsets in longitudinal colon and peripheral blood samples in immune checkpoint inhibitor-induced colitis.
    Mann JE; Lucca L; Austin MR; Merkin RD; Robert ME; Al Bawardy B; Raddassi K; Aizenbud L; Joshi NS; Hafler DA; Abraham C; Herold KC; Kluger HM
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell receptor sequencing reveals the clonal diversity and overlap of colonic effector and FOXP3+ T cells in ulcerative colitis.
    Lord J; Chen J; Thirlby RC; Sherwood AM; Carlson CS
    Inflamm Bowel Dis; 2015 Jan; 21(1):19-30. PubMed ID: 25437819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crossover Subsets of CD4
    Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose wogonin exacerbates DSS-induced colitis by up-regulating effector T cell function and inhibiting Treg cell.
    Xiao W; Yin M; Wu K; Lu G; Deng B; Zhang Y; Qian L; Jia X; Ding Y; Gong W
    J Cell Mol Med; 2017 Feb; 21(2):286-298. PubMed ID: 27641629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taking a daily vitamin to prevent type 1 diabetes?
    Wasserfall C; Atkinson MA
    Diabetes; 2009 Jan; 58(1):24-5. PubMed ID: 19114727
    [No Abstract]   [Full Text] [Related]  

  • 32. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
    Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation.
    Shibolet O; Alper R; Zolotarov L; Trop S; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Clin Immunol; 2004 Apr; 111(1):82-92. PubMed ID: 15093555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and function of immunosuppressive human and murine CD8+ T cells by transforming growth factor-β and retinoic acid.
    Fleissner D; Frede A; Knott M; Knuschke T; Geffers R; Hansen W; Dobos G; Langhorst J; Buer J; Westendorf AM
    Immunology; 2011 Sep; 134(1):82-92. PubMed ID: 21711349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Checkpoint Inhibitor Colitis Shows Drug-Specific Differences in Immune Cell Reaction That Overlap With Inflammatory Bowel Disease and Predict Response to Colitis Therapy.
    Lo YC; Price C; Blenman K; Patil P; Zhang X; Robert ME
    Am J Clin Pathol; 2021 Jul; 156(2):214-228. PubMed ID: 33555016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis.
    Koch Hansen L; Sevelsted-Møller L; Rabjerg M; Larsen D; Hansen TP; Klinge L; Wulff H; Knudsen T; Kjeldsen J; Köhler R
    J Crohns Colitis; 2014 Nov; 8(11):1378-91. PubMed ID: 24793818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-7 promotes long-term in vitro survival of unique long-lived memory subset generated from mucosal effector memory CD4+ T cells in chronic colitis mice.
    Takahara M; Nemoto Y; Oshima S; Matsuzawa Y; Kanai T; Okamoto R; Tsuchiya K; Nakamura T; Yamamoto K; Watanabe M
    Immunol Lett; 2013; 156(1-2):82-93. PubMed ID: 24070768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OX40 is required for regulatory T cell-mediated control of colitis.
    Griseri T; Asquith M; Thompson C; Powrie F
    J Exp Med; 2010 Apr; 207(4):699-709. PubMed ID: 20368580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total CD3 T Cells Are Necessary and Sufficient to Induce Colitis in Immunodeficient Mice With Dendritic Cell-Specific Deletion of TGFbR2: A Novel IBD Model to Study CD4 and CD8 T-Cell Interaction.
    Jamwal DR; Marati RV; Harrison CA; Midura-Kiela MT; Figliuolo Paz VR; Besselsen DG; Ghishan FK; Kiela PR
    Inflamm Bowel Dis; 2020 Jan; 26(2):229-241. PubMed ID: 31559420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL10-Deficiency in CD4⁺ T Cells Exacerbates the IFNγ and IL17 Response During Bacteria Induced Colitis.
    Seiffart V; Zoeller J; Klopfleisch R; Wadwa M; Hansen W; Buer J; Riedel C; Westendorf AM
    Cell Physiol Biochem; 2015; 36(4):1259-73. PubMed ID: 26160212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.